Revenue (Tables)

3 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	Three Months Ended March 31,
	2022	2021
Biologics	43 %	39 %
Generics	17 %	18 %
Pharma	24 %	24 %
Contract-Manufactured Products	16 %	19 %
	100 %	100 %

The following table presents the approximate percentage of our net sales by product category:

	Three Months Ended March 31,
	2022	2021
High-Value Product Components	56 %	52 %
High-Value Product Delivery Devices	5 %	5 %
Standard Packaging	23 %	24 %
Contract-Manufactured Products	16 %	19 %
	100 %	100 %

The following table presents the approximate percentage of our net sales by geographic location:

	Three Months Ended March 31,
	2022	2021
Americas	45 %	46 %
Europe, Middle East, Africa	45 %	44 %
Asia Pacific	10 %	10 %
	100 %	100 %

Schedule of Change in Contract With Customer, Asset and Liability

The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2021	$	14.6
Contract assets, March 31, 2022	14.8
Change in contract assets - increase (decrease)	$	0.2
Deferred income, December 31, 2021	$	(61.3)
Deferred income, March 31, 2022	(56.8)
Change in deferred income - decrease (increase)	$	4.5